Kolexia
Rose Johann Biologie médicale
Rose Johann
Biologie médicale
Centre Hospitalier du Mans
Le Mans, France
30 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Maladies de von Willebrand Leucémies Hémorragie Aberrations des chromosomes Paraprotéinémies Macroglobulinémie de Waldenström Métastase tumorale Maladie aigüe

Collaborateurs

Voir plus
Cussac Vincent
Cussac Vincent
Centre Hospitalier du Mans, Le Mans, France
Fouassier Marc
Fouassier Marc
Hôpital Hôtel-Dieu Nantes, Nantes, France
Trossaert Marc
Trossaert Marc
Hôpital Hôtel-Dieu Nantes, Nantes, France
Bayart Sophie
Bayart Sophie
Hôpital Sud Rennes, Rennes, France

Industries

Voir plus
Sobi
8 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
3 collaboration(s)
Dernière en 2023
AstraZeneca
3 collaboration(s)
Dernière en 2023
GSK
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Key Drivers of Coagulation Factor Use in Von Willebrand Disease During Hospitalization: An Overview of the French BERHLINGO Cohort.
Clinical drug investigation   30 novembre 2023
Efficacy and safety of turoctocog alfa in patients with hemophilia A requiring surgical procedures: A multicentre retrospective study.
Transfusion   18 octobre 2023
Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape.
Haematologica   01 décembre 2021
Real-world Annual Bleeding Rate in People with Severe Hemophilia A without Inhibitor on Prophylaxis, Comparing Switched to rFVIII-Fc versus Non-switched Patients: A Multicentre, Retrospective, Non interventional, before-after Study with the French BERHLINGO Database (MOTHIF-II)
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021
Real-world Use of FVIII in People with Severe Hemophilia A without Inhibitor on Prophylaxis, Comparing Switched to rFVIII-Fc versus Non-switched Patients: A Multicentre, Retrospective, Non Interventional, before-after Study with the French Nationwide Claims Database (MOTHIF-II)
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Blood advances   15 septembre 2020
Real-life Management of Digestive Endoscopies: Is There a Bleeding Risk for Patients with von Willebrand Disease?
Abstracts of the ISTH 2020 Virtual Congress of the International Society on Thrombosis and Haemostasis, July 12–14, 2020   11 août 2020
REAL-LIFE DATA OF CONSTITUTIONAL VON WILLEBRAND DISEASE IN WESTERN FRANCE (HOPSCOTcH-WILL): Multicenter Retrospective Study From 5 Hemostasis Treatment Centers in Western France: Severe Hemorrhagic Treated Occurrences' Patterns and Global Substitutive COagulation Factors THerapy in the Inherited Von WILLebrand Disease
Essai Clinique (CHU Nantes)   15 mai 2020
Abstracts
13th Annual Congress of European Association for Haemophilia and Allied Disorders 2020, 5–7 February 2020, The Hague, The Netherlands   28 janvier 2020
Lymphoplasmacytic lymphoma or multiple myeloma: immunoglobulins may lead to misdiagnosis.
Annales de biologie clinique   05 novembre 2018